Generics Need Sword, Shield For 'Exceptional' Patent Case
Generic drug companies marketing in the U.S. have particularly rough going these days. The year 2013 saw substantial new Generic Drug User Fee Amendments "user fees" levied on generics for access...To view the full article, register now.
Already a subscriber? Click here to view full article